Litigation Details for Allergan USA, Inc. v. Hetero Labs Limited (D. Del. 2020)
✉ Email this page to a colleague
Allergan USA, Inc. v. Hetero Labs Limited (D. Del. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-10-05 |
Court | District Court, D. Delaware | Date Terminated | 2021-10-20 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 7,741,356 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Allergan USA, Inc. v. Hetero Labs Limited
Details for Allergan USA, Inc. v. Hetero Labs Limited (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2020-10-02 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,741,356 B2. (kmd) (Entered:…2020 20 October 2021 1:20-cv-01344 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2021-10-20 | 84 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,741,356 B2. (Attachments: #…2020 20 October 2021 1:20-cv-01344 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |